AstraZeneca, Lilly, Novo Look To China Growth Despite Pricing Headwinds – Emerging Market Earnings Roundup (Part 1)

 
• By Brian Yang

In a recurring feature, PharmAsia News combs through quarterly earnings reports to bring you highlights on emerging markets.

More from Focus On Asia

More from Scrip